Your Gateway to Accelerated Early-Feasibility & First-In-Human Clinical Trial Results

bioaccess™ is Latin America’s leading contract research organization (CRO), providing world-class clinical research services to help you rapidly advance your medical device from feasibility to commercialization

shutterstock_1701221323.jpg
 

ABOUT US

We are experts in delivering cost-effective and high-quality CRO services in Latin America. We partner with Medtech startups seeking accelerated early-feasibility (EFS) or first-in-human (FIH) clinical study results. With bioaccess™, you quickly and reliably receive regulatory approval, clinical research site activation, subject recruitment, and clinical trial data.


TRUSTED BY

 
 

Why Colombia?

Imagine if you could conduct your early-feasibility (EFS) or first-in-human (FIH) clinical study on a +52-million-people country with 99% of its population covered by a top-performing universal healthcare system; with a 30-90 day national Ministry of Health (MoH) evaluation timeline for clinical trials; with OECD membership that ensures alignment of its legislation, policies, and practices to global first-world standards; and with a free-trade agreement with the US. Read more.

colombia-clinical trials-invima-regulatory registration.png
Mesa de trabajo 8.png
 

Testimonials

 

 

Team

bioaccess™ has an expert clinical research team. It includes members with over +20 years of proven experience in Latin America. They have processed and approved hundreds of regulatory dossier files in Latin America for first-in-human and early-feasibility studies.

Hernán Orjuela —a famous Colombian TV presenter— Interviews Julio G. Martinez-Clark, bioaccess™, CEO